Ronald Blue Trust, Inc. Rigel Pharmaceuticals Inc Transaction History
Ronald Blue Trust, Inc.
- $7.21 Billion
- Q2 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Rigel Pharmaceuticals Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 500 shares of RIGL stock, worth $6,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$6,840
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RIGL
# of Institutions
13Shares Held
355KCall Options Held
0Put Options Held
0-
Telemetry Investments, L.L.C. New York, NY323KShares$4.41 Million0.76% of portfolio
-
Barclays PLC London, X010.6KShares$144,6380.0% of portfolio
-
Bergan Kdv Wealth Management, LLC10KShares$136,8000.0% of portfolio
-
Flagship Harbor Advisors, LLC10KShares$136,8000.0% of portfolio
-
Ifp Advisors, Inc1KShares$13,6800.0% of portfolio
About RIGEL PHARMACEUTICALS INC
- Ticker RIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 172,836,000
- Market Cap $2.36B
- Description
- Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...